Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Progression of fibrosis in chronic hepatitis C.

Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, Herion D, Park Y, Liang TJ, Hoofnagle JH.

Gastroenterology. 2003 Jan;124(1):97-104.

PMID:
12512034
2.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
3.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
4.
5.

13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.

Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.

Dig Liver Dis. 2008 Sep;40(9):743-8. doi: 10.1016/j.dld.2008.01.013. Epub 2008 Mar 12.

PMID:
18339592
6.

Histological progression during short-term follow-up of patients with chronic hepatitis C virus infection.

Wali M, Lewis S, Hubscher S, Harrison R, Ahmed M, Elias E, Mutimer D.

J Viral Hepat. 1999 Nov;6(6):445-52.

PMID:
10607262
7.
8.

Fibrosis progression in initially mild chronic hepatitis C.

Boccato S, Pistis R, Noventa F, Guido M, Benvegnù L, Alberti A.

J Viral Hepat. 2006 May;13(5):297-302.

PMID:
16637859
9.

Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.

Collier JD, Woodall T, Wight DG, Shore S, Gimson AE, Alexander GJ.

J Viral Hepat. 2005 Jan;12(1):74-80.

PMID:
15655051
10.

Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?

Sanai FM, Benmousa A, Al-Hussaini H, Ashraf S, Alhafi O, Abdo AA, Alameri HF, Akbar HO, Bzeizi KI.

Liver Int. 2008 Aug;28(7):1011-8. doi: 10.1111/j.1478-3231.2008.01733.x. Epub 2008 Apr 1.

PMID:
18384520
12.

Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels.

Hui CK, Zhang HY, Shek T, Yao H, Yueng YH, Leung KW, Lai ST, Lai JY, Leung N, Lau GK.

Aliment Pharmacol Ther. 2007 Jun 1;25(11):1283-92.

13.

The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.

Kurosaki M, Matsunaga K, Hirayama I, Tanaka T, Sato M, Komatsu N, Umeda N, Hosokawa T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Asahina Y, Miyake S, Enomoto N, Izumi N.

J Hepatol. 2008 May;48(5):736-42. doi: 10.1016/j.jhep.2007.12.025. Epub 2008 Feb 26.

PMID:
18329125
14.

Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.

Hu SX, Kyulo NL, Xia VW, Hillebrand DJ, Hu KQ.

J Clin Gastroenterol. 2009 Sep;43(8):758-64. doi: 10.1097/MCG.0b013e31818be17c.

PMID:
19238091
15.

Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.

Forns X, Ampurdanès S, Sanchez-Tapias JM, Guilera M, Sans M, Sánchez-Fueyo A, Quintó L, Joya P, Bruguera M, Rodés J.

J Hepatol. 2001 Aug;35(2):265-71.

PMID:
11580150
16.

Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.

Taniguchi H, Iwasaki Y, Fujiwara A, Sakaguchi K, Moriya A, Yu PC, Takaki A, Fujioka S, Shimomura H, Shiratori Y.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):281-7.

PMID:
16460487
17.

Progression of initially mild hepatic fibrosis in patients with chronic hepatitis C infection.

Williams MJ, Lang-Lenton M; Trent HCV Study Group.

J Viral Hepat. 2011 Jan;18(1):17-22. doi: 10.1111/j.1365-2893.2009.01262.x.

PMID:
20088889
18.

Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.

Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL.

AIDS. 2007 Oct 18;21(16):2209-16.

PMID:
18090048
19.

Changes in liver histopathology in women infected with hepatitis C through contaminated anti-D immunoglobulin injections in Ireland.

Albloushi SS, Murray FE, Callagy G, Courtney MG, O'Keane JC, Kay E.

Eur J Gastroenterol Hepatol. 1998 Jan;10(1):69-73.

PMID:
9512956
20.

Rate of natural disease progression in patients with chronic hepatitis C.

Zarski JP, Mc Hutchison J, Bronowicki JP, Sturm N, Garcia-Kennedy R, Hodaj E, Truta B, Wright T, Gish R.

J Hepatol. 2003 Mar;38(3):307-14.

PMID:
12586296

Supplemental Content

Support Center